4/A
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0001567619-22-000782
Options or other derivatives
- Chief Executive Officer acquired 6,722 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Young David · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-12-31 | Grant or award : show line 1 in the form Restricted Stock Units | +6,722 | 22,780 | D |
Loading xslF345X03/doc1.xml…